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BRIEF COMMUNICATION
Cysticercus ANTIBODIES AND ANTIGENS IN SERUM FROM BLOOD DONORS FROM
PONDICHERRY, INDIA
Subhash Chandra PARIJA(1), N. BALAMURUGAN(3), Priyadarshi Soumyaranjan SAHU(1) & S.P. SUBBAIAH (2)
SUMMARY
The aim of the present study was to screen the serum of blood donors, which are apparently healthy and residing in Pondicherry
or its neighboring districts of Tamil Nadu State, for specific detection of Cysticercus antigens and antibodies. A total of 216 blood
samples were collected from blood donors at the Central Blood Bank, JIPMER Hospital, Pondicherry, India during January and
February 2004. Enzyme-linked immunosorbent assay (ELISA) was used to demonstrate anti-Cysticercus antibodies and the Co-
agglutination (CoA) was used to detect antigen in sera. 14 (6.48 %) males were positive for either anti-Cysticercus antibodies or
antigens. Of these eight sera were positive for anti-Cysticercus antibodies and six were positive for antigens. Results of the present
study show that serum Cysticercus antigen detection may be a useful adjunct to antibody testing for seroprevalence studies of
cysticercosis in the community. The present study is the first kind of study, carried out to determine both cysticercal antibodies as
well as antigens in the serum samples collected from the healthy blood donors.
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Taeniasis and cysticercosis caused by the cestode Taenia solium
are widely prevalent in human and porcine hosts in many developing
countries of Latin America, Africa and Asia. It has been estimated that
T. solium infections affect 50 million people and approximately 50,000
succumb to this disease worldwide every year8. Human cysticercosis
caused by Cysticercus cellulosae, the larval cysts of T. solium, results
from the ingestion of food, water and vegetables contaminated with T.
solium eggs or even by autoinfection in case of persons with intestinal
taeniasis. For each person with intestinal taeniasis, there are thought
to be 10 or more persons infected with the cystic stage of the parasite13.
The central nervous system (CNS) is the most common site of severe
symptomatic infection where the condition is referred to as
neurocysticercosis (NCC).
In India, the cases of cysticercosis including the NCC has been
documented from various parts of the country and is increasingly related
to the poor hygienic conditions especially in the slum dwellers and in
the certain pockets of the rural area. Most of the data are based on the
hospital-based studies, related to the clinical cases of NCC being
admitted in the hospitals for treatment. Diagnosis of these cases,
especially at the tertiary hospitals being made by imaging methods
such as CT and MRI; and frequently supplemented by serological tests.
Hospital based studies on autopsy of the brain documenting the cases
of NCC have also been documented from different parts of India
including Pondicherry18,20. However, population prevalence study on
human cysticercosis is less frequently reported from the country.
The aim of the present study was to screen the serum of blood
donors who are apparently healthy and residing in Pondicherry or its
neighboring districts of Tamil Nadu state for specific Cysticercus
antigens and antibodies using immunological techniques developed
and evaluated in this laboratory.
A total of 216 blood samples were collected from blood donors
randomly at the Central Blood Bank, JIPMER Hospital, Pondicherry
during January and February 2004 (The total number of donors we
have received at our hospital blood bank was 446 in the study period).
The median age of donors was 37 years (ranging from 18 years to 55
years) and number of male donors (95.37%) were predominant over
females (4.62%). The serum was separated and stored at –20 0C until
used.
ELISA was performed as per the procedure described by standard
method of CROWTHER with few modification4. Briefly, 1 µG protein
per 100 µL concentration of the antigen was prepared in antigen coating
buffer (PBS pH 7.2) as per the method described earlier17 and used for
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coating plates (NUNC) followed by blocking non-specific binding sites
by 2% BSA in PBS (pH 7.2). Optimum dilution (1:50) of test serum
sample and known Cysticercus antibody-positive serum samples were
prepared in sample dilution buffer were added in duplicate in the wells
and goat anti-human-IgG-HRP conjugated secondary antibody
(Bangalore Genei, India) was added to each well for detection. Substrate
solution prepared freshly by adding 6 mG of OPD in 10 mL of PBS




 (30%) was added just before to use. The




 in each well to
avoid over reaction and development of optimum colour. The
absorbance was taken at 492 nm in an ELISA reader (TEKAN).
Various controls were used for validity of the assay such as antigen
blank, antibody blank, negative control serum, and known positive
control serum. Serum sample which gave OD
492
 value of more than
cut-off (mean of 50 negative serum samples + 2 SD) was considered as
positive. The cut-off used in the present study was 0.157.
The Co-agglutination (Co-A) test to detect Cysticercus antigen in
the serum was carried out as per the method described by us before9.
In this test Cowan’s strain of Staphylococcus aureus rich in Protein A
(SAPA) cells, sensitized with polyclonal antibodies (hyperimmune
serum against C. cellulosae) were used to detect specific Cysticercus
antigen in the serum. The hyperimmune serum was used at the
concentration of 100 µL/ 10 mL of SAPA cells suspension (1%) as the
optimal sensitizing dose (OSD).
The test was performed on a glass slide, which was marked by a
pencil into two equal halves. 25 µL of the test serum was placed on
each half of the slide. An equal volume (25 µL) of sensitized SAPA
cell suspension (2%) was added to the test serum on one half. The
same volume (25 µL) of a suspension of unsensitized SAPA cells 2%
was added to the serum on another half of the glass slide as a cell
control. The slide was then rotated manually for two min and then
observed. In positive Co-A tests, the presence of Cysticercus antigen
was detected by the formation of large visible clumps of bacterial cells
within two min and clearing of the suspension in the test specimen. In
a negative reaction, no visible clumps were observed. Agglutination
with the sensitized cells and not with the unsensitized cells was
considered to be a positive reaction (Fig. 1). It is a qualitative test, so
there is no such cut-off used. Appropriate controls were put with each
test. With each batch, known positive and negative serum controls were
tested.
From the 216 studied subjects, screened for the Cysticercus antigens
and antibodies, 206 (95.3%) were male and 10 (4.62%) female. Of
these 14 males were positive for either Cysticercus antibodies or
antigens, which accounts 6.48% (14 out of 216) of the total number of
donors. The median age of 14 seropositive blood donors was 28.35
years (range from 19 to 36 years). No serum sample from female donors
was positive. ELISA demonstrated reactive Cysticercus antibody titre
in eight serum samples collected from blood donors. The Co-A detected
Cysticercus antigen in six (2.77 %) serum samples out of total 216
blood donors.
The seroprevalence of anti-Cysticercus antibodies in general
population has been found to vary from 1.2% to 21% as seen in several
endemic countries5,7,11,12,13,19. In a study carried out in Brazil, IgG
antibodies against total saline extract of C. cellulosae was detected in
blood donors where the 4.7%, 4.8%, 5.0% and 13.5% serum samples
were found to be positive for anti-Cysticercus antibodies in four
different cities. But in this study the serum samples were not screened
for Cysticercus antigens16. Similarly in another serological study in
Portugal a total of 489 individuals including the blood donors and
patients receiving treatment in the departments of orthopedics,
neurology and psychiatry, were tested for anti-Cysticercosis antibodies;
the overall seropositivity rate for Cysticercus antibodies among these
individuals was 12.1%. Cysticercus antibodies was detected in 14.9%
of the blood donors and patients from the department of orthopedics,
in 11.5% of the patients from the department of neurology, and 7.6%
of the patients from the department of psychiatry21.
In the present study 6.48% (14 out of 216) serum samples were
positive for either Cysticercus antibodies or antigens. Donors showing
a positive test, either by antigen or antibody assay were from Villupuram
(8.51%), Cuddalore (13.33%) and Thiruvanamalai (18.75%) districts,
that are immediately neighboring to Pondicherry (4.87%), indicating
the prevalence to be clustered in and around the studied place than the
districts located far away. However, further study with larger population
may be able to provide accurate information.
The presence of diagnostic anti-Cysticercus antibodies in eight
blood donors indicates that these donors either have suffered from
cysticercosis in past or having an infection with no overt clinical
manifestation. The mean titer of the negative subjects (i.e., 0.118) are
close to that of healthy normal controls (i.e., 0.117) where the mean
titer of positive subjects (i.e., 0.533) is higher than that of negative
subjects and close to that of positive control subjects (i.e., 0.355). The
antigen positive subjects showing a negative titre for antibody showed
the value a mean titer of 0.15, which is close to the cut-off OD (i.e.,
0.157).
Earlier studies including those in Brazil1,2 have detected the
prevalence of Cysticercus antibodies in sera of blood donors and other
patients but studies for detection of antigens in these individuals are
lacking. In the present study the Cysticercus antigen was detected in
sera of six (2.77%) blood donors by the Co-A test; the presence of
Cysticercus antigen in these persons may be due to sub-clinical
infections C. cellulosae. Because none of these donors gave any history
Fig. 1 - Antigen detection by Co-A: (a) test serum positive for antigen showing clumping
with cells sensitized with anti-Cysticercus antibody but no clumping with unsensitized cells;
and (b) test serum negative for antigen showing no clumping with either sensitized cells or
unsensitized cells.
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of having any overt clinical manifestations of NCC or other form of
cysticercosis. An interesting finding is that none of these Cysticercus
antigen-positive sera were positive for anti-Cysticercus antibodies. This
may be due to low or no response of the host to certain Cysticercus
antigens, which are recognized by polyclonal antibodies raised in rabbit.
Also could be those immunologically less reactive antigens usually
persisting longer in the circulation without a detectable antibody
response. Further characterization of the circulating antigens may be
necessary in support of this hypothesis, which was beyond the scope
of the present study.
The problem of a low sensitivity in the antibody detection test
may be due to no or low immune response in patients with cysticercosis,
as the cystic stages of the parasite may not evoke a strong detectable
antibody response while they remain alive and intact. Hence serological
study for Cysticercus antibodies alone may fail to detect all the cases
of cysticercosis and thus may not provide an accurate data on
seroprevalence of cysticercosis in the general population. Results of
the present study show that detection of Cysticercus antigen in serum
may be a useful adjunct to antibody testing for seroprevalence studies
of cysticercosis in the community. Also an antigen detection assay
provides useful evidence of recent infection as it is observed in case of
other parasitic diseases10. Combined antigen and antibody detection is
found to be always useful3.
The low sensitivity and specificity of the CoA test for antigen
detection, as observed in the present study may be due to the use of
polyclonal antibody that is raised against crude antigens of the parasite.
However, in an epidemiological study in endemic areas, an antigen
positive test along with the history of exposure to the parasite may
help in initial screening of the infected but asymptomatic subjects.
But for a confirmatory diagnosis there is need of developing a more
sensitive, specific as well as economically affordable serological tests
suitable for studies in developing countries.
RESUMO
Antígenos e anticorpos de Cysticercus em soro de doadores de
sangue de Pondicherry, Índia
O objetivo do presente estudo foi examinar o soro de doadores de
sangue que são aparentemente saudáveis e residentes em Pondicherry
ou seus distritos vizinhos do estado de Tamil Nadu, para a detecção
específica dos antígenos e anticorpos de Cysticercus. Um total de 216
amostras de sangue foram coletadas de doadores de sangue do “Central
Blood Bank, JIPMER Hospital”, Pondicherry, Índia, durante janeiro e
fevereiro de 2004. ELISA foi usado para demonstrar anticorpos anti-
Cysticercus e co-aglutinação (CoA) foi utilizada para detectar antígenos
no soro. 14 (6.48%) homens foram positivos para antígenos e anticorpos
anti-Cysticercus. Destes, oito soros foram positivos para anticorpos
anti-Cysticercus e seis positivos para antígenos. Os resultados do
presente estudo mostram que a detecção de antígenos de Cysticercus
no soro pode ser um adjunto útil para o teste de anticorpos para estudos
de soroprevalência de cisticercose na comunidade. O presente estudo
é o primeiro do tipo, realizado para determinar tanto anticorpos de
Cysticercus como antígenos nas amostras de soro coletadas de doadores
de sangue aparentemente saudáveis.
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